Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice

Arthritis Research and Therapy

Volumn 8, Issue 1, 2005, Pages

  García, Samuel ^a   Bodaño, Ana ^a   González, Antonio ^a   Forteza, Jerónimo ^a   Gómez Reino, Juan J ^b   Conde, Carmen ^a  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350510247     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1865     Document Type: Article

References (34)

1. Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell 1996, 85:307-310.
2. Firestein GS: Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
3. Loetscher P, Moser B: Homing chemokines in rheumatoid arthritis. Arthritis Res 2002, 4:233-236.
4. Choy EH, Panayi GS: Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001, 344:907-916.
5. Sweeney SE, FiresteRn GS: Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol 2004, 36 372-378.
6. Wong PK, Campbell IK, Egan PJ, Ernst M, Wicks IP: The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum 2003, 48:1177-1189.
7. Feldmann M, Brennan FM, Foxwell BM, Maini RN: The role of TNF alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 2001, 3 188-199.
8. Miossec P: An update on the cytokine network in rheumatoid arthritis Curr Opin Rheumatol 2004, 16:218-222.
9. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, et al.: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997, 337:141-147.
10. Gabay C, Arend WP: Treatment of rheumatoid arthritis with IL-1 inhibitors. Springer Semin Immunopathol 1998, 20:229-246.
11. de Murcia G, Ménissier-Ae Murcia J: Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 1994, 19 172-176.
12. Shall S, de Murcia G: PolW(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutation Res 2000, 460:1-15.
13. Oliver FJ, Ménissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G: Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly(ADP-ribose) polymerase-1 deficient mice. EMBO J 1999, 18:4446-4454.
14. Burkat V, Wang ZQ, Radons J, Heller B, Herceg Z, Stingl L, Wagner EF, Kolb H: Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic β-cell destruction and diabetes development induced by streptozocin. Nature Med 1999, 5:314-319.
15. Zingarelli B, Szabo C, Salzman AL: Blockade of Poly(ADPribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology 1999, 116 335-345.
16. Mabley JG, Jagtap P, Perretti M, Getting SJ, Salzman AL, Virág L, Szabó E, Soriano FJ, Liaudet L, Abdelkarim GE, et al.: Anti-inflammatory effects of a novel, potent inhibitor of poly(ADP-ribose) polymerase. Inflamm Res 2001, 50:561-569.
17. Szabó C, Dawson V: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998, 19:287-298.
18. Chang W-J, Alvarez-Gonzalez R: The sequence-specific DNA binding of NF-κB is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1. J Biol Chem 2001, 276 47664-47670.
19. Hassa PO, Hottiger MO: A role of poly(ADP-ribose) polymerase in NF-κB transcriptional activation. Biol Chem 1999, 380 953-959.
20. Ha HC, Hester LD, Snyder SH: Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci USA 2002, 99:3270-3275.
21. Andreone TL, O'Connor M, Denenberg A, Hake PW, Zingarelli B: Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. J Immunol 2003, 170 2113-2120.
22. de Murcia JM, Niedergan C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich A, LeMeur M, et al.: Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 1997, 94:7303-7307.
23. Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM: Induction of arthritis with monoclonal antibodies to collagen. J Immunol 1992, 148:2103-2108.
24. Conde C, Mark M, Oliver FJ, Huber A, de Murcia G, Ménissier-de Murcia J: Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice. EMBO J 2001, 20:3535-3543.
25. Szabo C, Lim LH, Cuzzocrea S, Getting SJ, Zingarelli B, Flower RJ, Salzman AL, Perretti M: Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects J Exp Med 1997, 186:1041-1049.
26. Amé JC, Spenlehauer C, de Murcia G: The PARP superfamily. BioEssays 2004, 26:882-893.
27. Bürkle A: Physiology and pathophysiology of poly(ADP-ribosyl) ation. BioEssays 2001, 23:795-806.
28. Szabo C, Virág L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, Zingarelli B, Salzman A, Kun E: Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 1998, 95:3867-3872.
29. Hom JT, Bendele AM, Carlson DG: In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice J Immunol 1998, 141:834-841.
30. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y: Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000, 191:313-320.
31. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM: Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992, 90:772-779.
32. Villiger PM, Terkeltaub R, Lotz M: Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 1992, 149:722-727.
33. Harigai M, Hara M, Yoshimura T, Leonard EJ, Inoue K, Kashiwazaki S: Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 1993, 69:83-91.
34. García-Vicuña R, Gómez-Gaviro MV, Domínguez-Luis MJ, Pec MK, González-Alvaro I, Alvaro-Gracia JM, Díaz-González F: CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum 2004, 50 3866-3877.